MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-12-2026
Envista Holdings Corporation ROCE Ratio 2011-2026 | NVST
Annual ROCE Ratio Envista Holdings Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.96 | -35.38 | 0.75 | 7.59 | 7.55 | 1.17 | 5.09 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 7.59 | -35.38 | -0.9 |
Quarterly ROCE Ratio Envista Holdings Corporation
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.12 | -36.1 | -36.9 | -34.96 | -33.7 | 6.87 | 5.46 | 7.34 | 7.28 | 7.72 | 6.42 | 8.49 | 6.41 | 8.96 | 7.15 | 8.81 | 8.4 | 2.95 | -1.92 | 0.31 | 0.87 | 5.92 | 5.64 | 7.32 | 6.79 | 4.64 | 1.69 | 1.69 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 8.96 | -36.9 | -0.44 |
ROCE Ratio of other stocks in the Medical instruments industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
9.3 | - | - | $ 810 M |  USA |
 |
Luminex Corporation
LMNX
|
5.75 | - | - | $ 1.75 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
-131.33 | - | -9.52 % | $ 20.6 M | USA |
 |
Alcon
ALC
|
-2.56 | $ 75.4 | -0.8 % | $ 40.4 B |  Schweiz |
 |
Ekso Bionics Holdings
EKSO
|
-147.62 | $ 11.21 | -1.41 % | $ 27.2 M | USA |
 |
The Cooper Companies
COO
|
8.29 | $ 63.09 | -1.94 % | $ 12.6 B | USA |
 |
Antares Pharma, Inc.
ATRS
|
9.12 | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
2.55 | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
-3.75 | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
11.0 | - | -0.05 % | $ 10.3 B | USA |
 |
Varian Medical Systems, Inc.
VAR
|
17.41 | - | -0.02 % | $ 16.3 B | USA |
 |
ICU Medical
ICUI
|
2.02 | $ 121.01 | -1.5 % | $ 2.98 B | USA |
 |
iRhythm Technologies
IRTC
|
-37.58 | $ 125.44 | -0.41 % | $ 4.01 B | USA |
 |
Haemonetics Corporation
HAE
|
27.02 | $ 59.84 | -1.06 % | $ 3.01 B | USA |
 |
electroCore
ECOR
|
769.63 | $ 6.15 | 1.32 % | $ 52.2 K | USA |
 |
Repro Med Systems
KRMD
|
-17.44 | $ 4.08 | 0.49 % | $ 188 M | USA |
 |
Isoray
ISR
|
-54.85 | - | 0.03 % | $ 108 M | USA |
 |
Intuitive Surgical
ISRG
|
16.53 | $ 466.64 | -0.92 % | $ 167 B | USA |
 |
Microbot Medical
MBOT
|
-19.01 | $ 2.1 | -3.23 % | $ 96.2 M |  Israel |
 |
Glaukos Corporation
GKOS
|
-27.87 | $ 119.63 | -2.0 % | $ 5.79 B | USA |
 |
Milestone Scientific
MLSS
|
-202.54 | $ 0.33 | -4.15 % | $ 27.1 M | USA |
 |
Masimo Corporation
MASI
|
-25.35 | $ 178.51 | -0.08 % | $ 9.51 B | USA |
 |
InfuSystem Holdings
INFU
|
3.45 | $ 10.18 | -4.5 % | $ 210 M | USA |
 |
Merit Medical Systems
MMSI
|
11.66 | $ 66.74 | -1.02 % | $ 3.95 B | USA |
 |
Pulse Biosciences
PLSE
|
-95.39 | $ 21.83 | -3.62 % | $ 1.47 B | USA |
 |
Retractable Technologies
RVP
|
-28.47 | $ 0.62 | -2.99 % | $ 18.6 M | USA |
 |
Pro-Dex
PDEX
|
22.96 | $ 51.51 | -0.87 % | $ 169 M | USA |
 |
LeMaitre Vascular
LMAT
|
17.26 | $ 112.4 | -1.85 % | $ 2.54 B | USA |
 |
STAAR Surgical Company
STAA
|
-26.65 | $ 26.7 | 0.07 % | $ 1.32 B | USA |
 |
STERIS plc
STE
|
13.12 | $ 219.75 | -1.1 % | $ 21.7 B | USA |
 |
Predictive Oncology
POAI
|
-379.14 | - | - | $ 31.1 M | USA |
 |
Teleflex Incorporated
TFX
|
0.44 | $ 135.52 | 0.33 % | $ 6.05 B | USA |
 |
BioLife Solutions
BLFS
|
-2.04 | $ 20.9 | -2.38 % | $ 963 M | USA |
 |
Stereotaxis
STXS
|
-164.02 | $ 1.86 | -3.63 % | $ 169 M | USA |
 |
Baxter International
BAX
|
-5.03 | $ 17.94 | -2.97 % | $ 9.2 B | USA |
 |
ResMed
RMD
|
22.7 | $ 217.14 | -2.2 % | $ 31.7 B | USA |
 |
AtriCure
ATRC
|
-1.92 | $ 28.48 | -1.93 % | $ 1.36 B | USA |
 |
Utah Medical Products
UTMD
|
9.56 | $ 66.61 | -0.25 % | $ 216 M | USA |
 |
Harvard Bioscience
HBIO
|
-353.72 | $ 6.45 | -5.56 % | $ 286 M | USA |
 |
NeuroMetrix
NURO
|
-61.36 | - | 5.05 % | $ 9.02 M | USA |
 |
West Pharmaceutical Services
WST
|
18.42 | $ 292.13 | -3.33 % | $ 21.1 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
-31.52 | $ 11.78 | -1.51 % | $ 2.35 B | USA |
 |
AngioDynamics
ANGO
|
-21.84 | $ 10.98 | -0.99 % | $ 449 M | USA |
 |
Becton, Dickinson and Company
BDX
|
10.16 | $ 149.52 | -0.47 % | $ 43 B | USA |
 |
Nephros
NEPH
|
-19.06 | $ 3.32 | 2.79 % | $ 34.5 M | USA |
 |
OraSure Technologies
OSUR
|
-19.81 | $ 3.01 | - | $ 221 M | USA |
 |
Repligen Corporation
RGEN
|
1.79 | $ 117.43 | -0.73 % | $ 6.54 M | USA |